NUY-17382-09917 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-08-05
Dose 1 — Pfizer-BioNTech
Co-administered: Hepatitis B:Pneumonia:Polio:Rotavirus:Tetanus
2022-08-26
Dose 2 — Pfizer-BioNTech
2022-09-12
Registered in v-safe
2022-09-12
Survey response — day 14, dose 2, under 3
MedDRA: Ear infection, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school

Free text: Congestion, fever, double ear infection

MedDRA releases: 2024-11 · check-in free text available
2022-09-18
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-23
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-30
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-07
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-21
Dose 3 — Pfizer-BioNTech

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-05	Pfizer-BioNTech	Hepatitis B:Pneumonia:Polio:Rotavirus:Tetanus
2	2022-08-26	Pfizer-BioNTech	No
3	2022-10-21	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-09-12

Symptoms: Congestion, fever, double ear infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ear infection	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release